Laboratory diagnosis of pertussis

Clinical Microbiology Reviews

Volumn 28, Issue 4, 2015, Pages 1005-1026

  van der Zee, Anneke ^a   Schellekens, Joop F P ^b   Mooi, Frits R ^c,d  

^a Maasstad Hospital   (Netherlands)

^b Certe Laboratory for Infectious Diseases ^*  (Netherlands)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACELLULAR VACCINE; IMMUNOGLOBULIN G; BACTERIAL VACCINE;

ARTICLE; CLUSTER ANALYSIS; CROSS REACTION; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; LABORATORY DIAGNOSIS; NONHUMAN; PARASITE SERODIAGNOSIS; PERTUSSIS; POLYMERASE CHAIN REACTION; QUALITY CONTROL; SENSITIVITY AND SPECIFICITY; AGE; LABORATORY TEST; WHOOPING COUGH;

AGE FACTORS; BACTERIAL VACCINES; CLINICAL LABORATORY TECHNIQUES; HUMANS; WHOOPING COUGH;

EID: 84941636277     PISSN: 08938512     EISSN: 10986618     Source Type: Journal    
DOI: 10.1128/CMR.00031-15     Document Type: Article

References (274)

1. Roush SW, Murphy TV, Vaccine-Preventable Disease Table Working Group. 2007. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. JAMA 298:2155–2163.http://dx.doi.org/10.1001/jama.298.18.2155.
2. Mills KH, Ross PJ, Allen AC, Wilk MM. 2014. Do we need a new vaccine to control the re-emergence of pertussis? Trends Microbiol 22:49–52. http://dx.doi.org/10.1016/j.tim.2013.11.007.
3. Mooi FR, Van Der Maas NA, De Melker HE. 2014. Pertussis resurgence: waning immunity and pathogen adaptation—two sides of the same coin. Epidemiol Infect 142:685–694. http://dx.doi.org/10.1017/S0950268813000071.
4. Berbers GA, de Greeff SC, Mooi FR. 2009. Improving pertussis vaccination. Hum Vaccin 5:497–503. http://dx.doi.org/10.4161/hv.8112.
5. Witt MA, Arias L, Katz PH, Truong ET, Witt DJ. 2013. Reduced risk of pertussis among persons ever vaccinated with whole cell pertussis vaccine compared to recipients of acellular pertussis vaccines in a large US cohort. Clin Infect Dis 56:1248–1254. http://dx.doi.org/10.1093/cid/cit046.
6. Liko J, Robison SG, Cieslak PR. 2013. Priming with whole-cell versus acellular pertussis vaccine. N Engl J Med 368:581–582. http://dx.doi.org/10.1056/NEJMc1212006.
7. Witt MA, Katz PH, Witt DJ. 2012. Unexpectedly limited durability of immunity following acellular pertussis vaccination in pre-adolescents in a North American outbreak. Clin Infect Dis 54:1730–1735. http://dx.doi.org/10.1093/cid/cis287.
8. Sheridan SL, Ware RS, Grimwood K, Lambert SB. 2012. Number and order of whole cell pertussis vaccines in infancy and disease protection. JAMA 308:454–456. http://dx.doi.org/10.1001/jama.2012.6364.
9. de Melker HE, Versteegh FG, Conyn-Van Spaendonck MA, Elvers LH, Berbers GA, van der Zee A, Schellekens JF. 2000. Specificity and sensitivity of high levels of immunoglobulinGantibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis. J Clin Microbiol 38:800–806.
10. Güris¸ D, Strebel PM, Bardenheier B, Brennan M, Tachdjian R, Finch E, Wharton M, Livengood JR. 1999. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990–1996. Clin Infect Dis 28:1230–1237. http://dx.doi.org/10.1086/514776.
11. Cherry JD. 2014. Adult pertussis in the pre- and post-vaccine eras: lifelong vaccine-induced immunity? Expert Rev Vaccines 13:1073–1080. http://dx.doi.org/10.1586/14760584.2014.935765.
12. de Greeff SC, de Melker HE, van Gageldonk PGM, Schellekens JFP, van der Klis FRM, Mollema L, Mooi FR, Berbers GAM. 2010. Seroprevalence of pertussis in the Netherlands: evidence for increased circulation of Bordetella pertussis. PLoS One 5:e14183. http://dx.doi.org/10.1371/journal.pone.0014183.
13. Wirsing von König CH, Halperin S, Riffelmann M, Guiso N. 2002. Pertussis of adults and infants. Lancet Infect Dis 2:744–750. http://dx.doi.org/10.1016/S1473-3099(02)00452-8.
14. European Centre for Disease Prevention and Control. 2013. Annual epidemiological report. Reporting on 2011 surveillance data and 2012 epidemic intelligence data. ECDC, Stockholm, Sweden.
15. ECDC. 2012. Guidance and protocol for the use of real-time PCR in laboratory diagnosis of human infection with Bordetella pertussis or Bordetella parapertussis. ECDC, Stockholm, Sweden. http://ecdc.europa.eu/en/publications/Publications/Guidance-protocol-PCR-laboratory-diagnosis-bordetella-pertussis-parapertussis.pdf.
16. Centers for Disease Control and Prevention. 2007. Outbreaks of respiratory illness mistakenly attributed to pertussis—New Hampshire, Massachusetts, and Tennessee, 2004–2006.MMWRMorb Mortal Wkly Rep 56:837–842.
17. Wirsing von König CH, Rott H, Bogaerts H, Schmitt HJ. 1998. A serologic study of organisms possibly associated with pertussis-like coughing. Pediatr Infect Dis J 17:645–649. http://dx.doi.org/10.1097/00006454-199807000-00013.
18. Diavatopoulos DA, Cummings CA, van der Heide HG, van Gent M, Liew S, Relman DA, Mooi FR. 2006. Characterization of a highly conserved island in the otherwise divergent Bordetella holmesii and Bordetella pertussis genomes. J Bacteriol 188:8385–8394. http://dx.doi.org/10.1128/JB.01081-06.
19. Diavatopoulos DA, Cummings CA, Schouls LM, Brinig MM, Relman DA, Mooi FR. 2005. Bordetella pertussis, the causative agent of whooping cough, evolved from a distinct, human-associated lineage of B. bronchiseptica. PLoS Pathog 1:e45.
20. Cullinane LC, Alley MR, Marshall RB, Manktelow BW. 1987. Bordetella parapertussis from lambs. N Z Vet J 35:175. http://dx.doi.org/10.1080/00480169.1987.35433.
21. He Q, Viljanen MK, Arvilommi H, Aittanen B, Mertsola J. 1998. Whooping cough caused by Bordetella pertussis and Bordetella parapertussis in an immunized population. JAMA 280:635–637. http://dx.doi.org/10.1001/jama.280.7.635.
22. Yih WK, Silva EA, Ida J, Harrington N, Lett SM, George H. 1999. Bordetella holmesii-like organisms isolated from Massachusetts patients with pertussis-like symptoms. Emerg Infect Dis 5:441–443. http://dx.doi.org/10.3201/eid0503.990317.
23. Mastrantonio P, Stefanelli P, Giuliano M, Herrera Rojas Y, Ciofi degli Atti M, Anemona A, Tozzi AE. 1998. Bordetella parapertussis infection in children: epidemiology, clinical symptoms, and molecular characteristics of isolates. J Clin Microbiol 36:999–1002.
24. Woolfrey BF, Moody JA. 1991. Human infections associated with Bordetella bronchiseptica. Clin Microbiol Rev 4:243–255.
25. CDC. 2014. Pertussis/whooping cough (Bordetella pertussis) 2014 case definition. CDC, Atlanta, GA. http://wwwn.cdc.gov/nndss/script/casedef.aspx?CondYrID_950&DatePub_1/1/2014%2012:00:00%20AM.
26. ECDC. 2012. Pertussis. ECDC, Stockholm, Sweden. http://ecdc.europa.eu/en/activities/surveillance/euvac/case_definition/Pages/pertusis.aspx.
27. WHO. 2008. WHO-recommended surveillance standard of pertussis. http://www.who.int/immunization/monitoring_surveillance/burden/vpd/surveillance:type/passive/pertussis_standards/en/.
28. Cherry JD, Grimprel E, Guiso N, Heininger U, Mertsola J. 2005. Defining pertussis epidemiology: clinical, microbiologic and serologic perspectives. Pediatr Infect Dis J 24(Suppl 5):S25–S34. http://dx.doi.org/10.1097/01.inf.0000160926.89577.3b.
29. Cherry JD, Tan T, Wirsing von König CH, Forsyth KD, Thisyakorn U, Greenberg D, Johnson D, Marchant C, Plotkin S. 2012. Clinical definitions of pertussis: summary of a Global Pertussis Initiative roundtable meeting, February 2011. Clin Infect Dis 54:1756–1764. http://dx.doi.org/10.1093/cid/cis302.
30. Miyashita N, Akaike H, Teranishi H, Kawai Y, Ouchi K, Kato T, Hayashi T, Okimoto N. 2013. Diagnostic value of symptoms and laboratory data for pertussis in adolescent and adult patients. BMCInfect Dis 13:129. http://dx.doi.org/10.1186/1471-2334-13-129.
31. Steketee RW, Wassilak SG, Adkins WN, Jr, Burstyn DG, Manclark CR, Berg J, Hopfensperger D, Schell WL, Davis JP. 1988. Evidence for a high attack rate and efficacy of erythromycin prophylaxis in a pertussis outbreak in a facility for the developmentally disabled. J Infect Dis 157:441–449. http://dx.doi.org/10.1093/infdis/157.3.441.
32. Paddock CD, Sanden GN, Cherry JD, Gal AA, Langston C, Tatti KM, Wu KH, Goldsmith CS, Greer PW, Montague JL, Eliason MT, Holman RC, Guarner J, Shieh WJ, Zaki SR. 2008. Pathology and pathogenesis of fatal Bordetella pertussis infection in infants. Clin Infect Dis 47:328–338. http://dx.doi.org/10.1086/589753.
33. Bejuk J, Begovac J, Bace A, Kuzmanovic-Sterk N, Aleraj B. 1995. Culture of Bordetella pertussis from three upper respiratory tract specimens. Pediatr Infect Dis J 14:64–65.
34. Marcon MJ, Hamoudi AC, Cannon HJ, Hribar MM. 1987. Comparison of throat and nasopharyngeal swab specimens for culture diagnosis of Bordetella pertussis infection. J Clin Microbiol 25:1109–1110.
35. CDC. 2011. Pertussis (whooping cough) specimen collection. CDC, Atlanta, GA. http://www.cdc.gov/pertussis/clinical/diagnostic-testing/specimen-collection.html.
36. Hallander HO, Reizenstein E, Renemar B, Rasmuson G, Mardin L, Olin P. 1993. Comparison of nasopharyngeal aspirates with swabs for culture of Bordetella pertussis. J Clin Microbiol 31:50–52.
37. Cloud JL, Hymas WC, Carroll KC. 2002. Impact of nasopharyngeal swab types on detection of Bordetella pertussis by PCR and culture. J Clin Microbiol 40:3838–3840. http://dx.doi.org/10.1128/JCM.40.10.3838-3840.2002.
38. Wadowsky RM, Laus S, Libert T, States SJ, Ehrlich GD. 1994. Inhibition of PCR-based assay for Bordetella pertussis by using calcium alginate fiber and aluminum shaft components of a nasopharyngeal swab. J Clin Microbiol 32:1054–1057.
39. Dube FS, Kaba M, Whittaker E, Zar HJ, Nicol MP. 2013. Detection of Streptococcus pneumoniae from different types of nasopharyngeal swabs in children. PLoS One 8:e68097. http://dx.doi.org/10.1371/journal.pone.0068097.
40. Vestrheim DF, Steinbakk M, Bjørnstad ML, Moghaddam A, Reinton N, Dahl ML, Grude N, Sandvena P. 2012. Recovery of Bordetella pertussis from PCR-positive nasopharyngeal samples is dependent on bacterial load. J Clin Microbiol 50:4114–4115. http://dx.doi.org/10.1128/JCM.01553-12.
41. Pittet LF, Emonet S, Schrenzel J, Siegrist CA, Posfay-Barbe KM. 2014. Bordetella holmesii: an under-recognised Bordetella species. Lancet Infect Dis 14:510–519. http://dx.doi.org/10.1016/S1473-3099(14)70021-0.
42. Hoppe JE, Schwaderer J. 1989. Direct plating versus use of transport medium for detection of Bordetella species from nasopharyngeal swabs. Eur J Clin Microbiol Infect Dis 8:264–265. http://dx.doi.org/10.1007/BF01965276.
43. Katzko G, Hofmeister M, Church D. 1996. Extended incubation of culture plates improves recovery of Bordetella spp. J Clin Microbiol 34: 1563–1564.
44. Bart MJ, Harris SR, Advani A, Arakawa Y, Bottero D, Bouchez V, Cassiday PK, Chiang CS, Dalby T, Fry NK, Gaillard ME, van Gent M, Guiso N, Hallander HO, Harvill ET, He Q, van der Heide HG, Heuvelman K, Hozbor DF, Kamachi K, Karataev GI, Lan R, Lutynska A, Maharjan RP, Mertsola J, Miyamura T, Octavia S, Preston A, Quail MA, Sintchenko V, Stefanelli P, Tondella ML, Tsang RS, Xu Y, Yao SM, Zhang S, Parkhill J, Mooi FR. 2014. Global population structure and evolution of Bordetella pertussis and their relationship with vaccination. mBio 5:e01074. http://dx.doi.org/10.1128/mBio.01074-14.
45. de Gouw D, Hermans PW, Bootsma HJ, Zomer A, Heuvelman K, Diavatopoulos DA, Mooi FR. 2014. Differentially expressed genes in Bordetella pertussis strains belonging to a lineage which recently spread globally. PLoS One 9:e84523. http://dx.doi.org/10.1371/journal.pone.0084523.
46. de Gouw DSD, de Jonge MI, Hermans PWM, Wessels HJCT, Zomer A, Yantorno OM, Diavatopoulos DA, Mooi FR. 2014. The vaccine potential of Bordetella pertussis biofilm-derived membrane proteins. Emerg Microbes Infect 3:e58. http://dx.doi.org/10.1038/emi.2014.58.
47. Parkhill J, Sebaihia M, Preston A, Murphy LD, Thomson N, Harris DE, Holden MT, Churcher CM, Bentley SD, Mungall KL, Cerdeño- Tárraga AM, Temple L, James K, Harris B, Quail MA, Achtman M, Atkin R, Baker S, Basham D, Bason N, Cherevach I, Chillingworth T, Collins M, Cronin A, Davis P, Doggett J, Feltwell T, Goble A, Hamlin N, Hauser H, Holroyd S, Jagels K, Leather S, Moule S, Norberczak H, O’Neil S, Ormond D, Price C, Rabbinowitsch E, Rutter S, Sanders M, Saunders D, Seeger K, Sharp S, Simmonds M, Skelton J, Squares R, Squares S, Stevens K, Unwin L, Whitehead S, Barrell BG, Maskell DJ. 2003. Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nat Genet 35:32–40. http://dx.doi.org/10.1038/ng1227.
48. Ewanowich CA, Chui LWL, Paranchych MG, Peppler MS, Marusyk RG, Albrittons WL. 1993. Major outbreak of pertussis in northern Alberta, Canada: analysis of discrepant direct fluorescent-antibody and culture results by using polymerase chain reaction methodology. J Clin Microbiol 31:1715–1725.
49. Loeffelholz M. 2012. Towards improved accuracy of Bordetella pertussis nucleic acid amplification tests. J Clin Microbiol 50:2186–2190. http://dx.doi.org/10.1128/JCM.00612-12.
50. Riffelmann M, Wirsing von Konig CH, Caro V, Guiso N. 2005. Nucleic acid amplification tests for diagnosis of Bordetella infections. J Clin Microbiol 43:4925–4929. http://dx.doi.org/10.1128/JCM.43.10.4925-4929.2005.
51. Notomi T, Okayama H, Masubuchi H, Yonekawa T, Watanabe K, Amino N, Hase T. 2000. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res 28:E63. http://dx.doi.org/10.1093/nar/28.12.e63.
52. Notomi T, Mori Y, Tomita N, Kanda H. 2015. Loop-mediated isothermal amplification (LAMP): principle, features, and future prospects. J Microbiol 53:1–5. http://dx.doi.org/10.1007/s12275-015-4656-9.
53. Kamachi K, Toyoizumi-Ajisaka H, Toda K, Soeung SC, Sarath S, Nareth Y, Horiuchi Y, Kojima K, Takahashi M, Arakawa Y. 2006. Development and evaluation of a loop-mediated isothermal amplification method for rapid diagnosis of Bordetella pertussis infection. J Clin Microbiol 44:1899–1902. http://dx.doi.org/10.1128/JCM.44.5.1899-1902.2006.
54. Vincent M, Xu Y, Kong H. 2004. Helicase-dependent isothermal DNA amplification. EMBO Rep 5:795– 800. http://dx.doi.org/10.1038/sj.embor.7400200.
55. van Kruijssen AM, Templeton KE, van der Plas RN, van Doorn HR, Claas EC, Sukhai RN, Kuijper EJ. 2007. Detection of respiratory pathogens by real-time PCR in children with clinical suspicion of pertussis. Eur J Pediatr 166:1189–1191. http://dx.doi.org/10.1007/s00431-006-0378-7.
56. Kumar S, Wang L, Fan J, Kraft A, Bose ME, Tiwari S, Van Dyke M, Haigis R, Luo T, Ghosh M, Tang H, Haghnia M, Mather EL, Weisburg WG, Henrickson KJ. 2008. Detection of 11 common viral and bacterial pathogens causing community-acquired pneumonia or sepsis in asymptomatic patients by using a multiplex reverse transcription-PCR assay with manual (enzyme hybridization) or automated (electronic microarray) detection. J Clin Microbiol 46:3063–3072. http://dx.doi.org/10.1128/JCM.00625-08.
57. McDonough EA, Barrozo CP, Russell KL, Metzgar D. 2005. A multiplex PCR for detection of Mycoplasma pneumoniae, Chlamydophila pneumoniae, Legionella pneumophila, and Bordetella pertussis in clinical specimens. Mol Cell Probes 19:314–322. http://dx.doi.org/10.1016/j.mcp.2005.05.002.
58. Wang Y, Kong F, Yang Y, Gilbert GL. 2008. A multiplex PCR-based reverse line blot hybridization (mPCR/RLB) assay for detection of bacterial respiratory pathogens in children with pneumonia. Pediatr Pulmonol 43:150–159. http://dx.doi.org/10.1002/ppul.20749.
59. Chan EL, Antonishyn N, McDonald R, Maksymiw T, Pieroni P, Nagle E, Horsman GB. 2002. The use of TaqMan PCR assay for detection of Bordetella pertussis infection from clinical specimens. Arch Pathol Lab Med 126:173–176.
60. He Q, Mertsola J, Soini H, Viljanen MK. 1994. Sensitive and specific polymerase chain reaction assays for detection of Bordetella pertussis in nasopharyngeal specimens. J Pediatr 124:421–426. http://dx.doi.org/10.1016/S0022-3476(94)70365-5.
61. Mandal S, Tatti KM, Woods-Stout D, Cassiday PK, Faulkner AE, Griffith MM, Jackson ML, Pawloski LC, Wagner B, Barnes M, Cohn AC, Gershman KA, Messonnier NE, Clark TA, Tondella ML, Martin SW. 2012. Pertussis pseudo-outbreak linked to specimens contaminated by Bordetella pertussis DNA from clinic surfaces. Pediatrics 129:e424–e430. http://dx.doi.org/10.1542/peds.2011-1710.
62. Rantakokko-Jalava K, Jalava J. 2002. Optimal DNA isolation method for detection of bacteria in clinical specimens by broad-range PCR. J Clin Microbiol 40:4211–4217. http://dx.doi.org/10.1128/JCM.40.11.4211-4217.2002.
63. Riffelmann M, Schmetz J, Bock S, Wirsing von Koenig CH. 2008. Preparation of Bordetella pertussis DNA from respiratory samples for real-time PCR by commercial kits. Eur J Clin Microbiol Infect Dis 27: 145–148. http://dx.doi.org/10.1007/s10096-007-0403-4.
64. Dundas N, Leos NK, Mitui M, Revell P, Rogers BB. 2008. Comparison of automated nucleic acid extraction methods with manual extraction. J Mol Diagn 10:311–316. http://dx.doi.org/10.2353/jmoldx.2008.070149.
65. Caro V, Guiso N, Alberti C, Liguori S, Burucoa C, Couetdic G, Doucet-Populaire F, Ferroni A, Papin-Gibaud S, Grattard F, Réglier- Poupet H, Raymond J, Soler C, Bouchet S, Charreau S, Couzon B, Leymarie I, Tavares N, Choux M, Bingen E, Bonacorsi S. 2009. Proficiency program for real-time PCR diagnosis of Bordetella pertussis infections in French hospital laboratories and at the French National Reference Center for Whooping Cough and other Bordetelloses. J Clin Microbiol 47:3197–3203. http://dx.doi.org/10.1128/JCM.00817-09.
66. McLafferty MA, Harcus DR, Hewlett EL. 1988. Nucleotide sequence and characterization of a repetitive DNA element from the genome of Bordetella pertussis with characteristics of an insertion sequence. J Gen Microbiol 134:2297–2306.
67. van der Zee A, Agterberg C, van Agterfeld M, Peeters M, Mooi FR. 1993. Characterization of IS1001, an insertion sequence element of Bordetella parapertussis. J Bacteriol 175:141–147.
68. van der Zee A, Groenendijk H, Peeters M, Mooi FR. 1996. The differentiation of Bordetella parapertussis and Bordetella bronchiseptica from humans and animals as determined by DNA polymorphism mediated by two different insertion sequence elements suggests their phylogenetic relationship. Int J Syst Bacteriol 46:640–647. http://dx.doi.org/10.1099/00207713-46-3-640.
69. van der Zee A, Mooi FR, van Embden J, Musser J. 1997. Molecular evolution and host adaptation of Bordetella spp.: phylogenetic analysis using multilocus enzyme electrophoresis and typing with three insertion sequences. J Bacteriol 179:6609–6617.
70. Aoyama T, Tamura C, Takeuchi Y, Kamimura T, Imaizumi A. 1997. Rapid, sensitive and specific diagnosis of Bordetella pertussis using the polymerase chain reaction. Acta Paediatr 39:44–47. http://dx.doi.org/10.1111/j.1442-200X.1997.tb03554.x.
71. Dragsted DM, Dohn B, Madsen J, Jensen JS. 2004. Comparison of culture and PCR for detection of Bordetella pertussis and Bordetella parapertussis under routine laboratory conditions. J Med Microbiol 53: 749–754. http://dx.doi.org/10.1099/jmm.0.45585-0.
72. Glare EM, Paton JC, Premier RR, Lawrence AJ, Nisbet IT. 1990. Analysis of a repetitive DNA sequence from Bordetella pertussis and its application to the diagnosis of pertussis using the polymerase chain reaction. J Clin Microbiol 28:1982–1987.
73. Grimprel E, Bégué P, Anjak I, Betsou F, Guiso N. 1993. Comparison of polymerase chain reaction, culture and Western immunoblot serology for diagnosis of Bordetella pertussis infections. J Clin Microbiol 31:2745–2750.
74. He Q, Mertsola J, Soini H, Skurnik M, Ruuskanen O, Viljanen MK. 1993. Comparison of polymerase chain reaction with culture and enzyme immunoassay for diagnosis of pertussis. J Clin Microbiol 31:642–645.
75. Lichtinghagen R, Diedrich-Glaubitz R, von Hörsten B. 1994. Identification of Bordetella pertussis in nasopharyngeal swabs using the polymerase chain reaction: evaluation of detection methods. Eur J Clin Chem Clin Biochem 32:161–167.
76. Loeffelholz MJ, Thompson CJ, Long KS, Gilchrist MJ. 1999. Comparison of PCR, culture, and direct fluorescent-antibody testing for detection of Bordetella pertussis. J Clin Microbiol 37:2872–2876.
77. Nelson S, Matlow A, McDowell C, Roscoe M, Karmali M, Penn L, Dyster L. 1997. Detection of Bordetella pertussis in clinical specimens by PCR and a microtiter plate-based DNA hybridization assay. J Clin Microbiol 35:117–120.
78. Olcen P, Bäckman A, Johansson B, Esbjorner E, Tornqvist E, Dygraves J, McPheat WL. 1992. Amplification of DNA by the polymerase chain reaction for the efficient diagnosis of pertussis. Scand J Infect Dis 24:339–345. http://dx.doi.org/10.3109/00365549209061340.
79. Wadowsky RM, Michaels RH, Libert T, Kingsley LA, Ehrlich GD. 1996. Multiplex PCR-based assay for detection of Bordetella pertussis in nasopharyngeal swab specimens. J Clin Microbiol 34:2645–2649.
80. Bidet P, Liguori S, De Lauzanne A, Caro V, Lorrot M, Carol A, Faye A, Guiso N, Bingen E, Bonacorsi S. 2008. Real-time PCR measurement of persistence of Bordetella pertussis DNA in nasopharyngeal secretions during antibiotic treatment of young children with pertussis. J Clin Microbiol 46:3636–3638. http://dx.doi.org/10.1128/JCM.01308-08.
81. Bäckman A, Johansson B, Olcen P. 1994. Nested PCR optimized for detection of Bordetella pertussis in clinical nasopharyngeal samples. J Clin Microbiol 32:2544–2548.
82. De Donno A, Quattrocchi M, Ansaldi F, Campa A, Rollo MC, Gabutti G. 2006. Direct detection of Bordetella pertussis and Bordetella parapertussis: comparison of polymerase chain reaction and culture. J Int Med Res 34:367–373. http://dx.doi.org/10.1177/147323000603400405.
83. Farrell DJ, Daggard G, Mukkur TK. 1999. Nested duplex PCR to detect Bordetella pertussis and Bordetella parapertussis and its application in diagnosis of pertussis in nonmetropolitan Southeast Queensland, Australia. J Clin Microbiol 37:606–610.
84. Reizenstein E, Lindberg L, Möllby R, Hallander HO. 1996. Validation of nested Bordetella PCR in pertussis vaccine trial. J Clin Microbiol 34: 810–815.
85. Farrell DJ, McKeon M, Daggard G, Loeffelholz MJ, Thompson CJ, Mukkur TK. 2000. Rapid-cycle PCR method to detect Bordetella pertussis that fulfills all consensus recommendations for use of PCR in diagnosis of pertussis. J Clin Microbiol 38:4499–4502.
86. Fry NK, Tzivra O, Li YT, McNiff A, Doshi N, Maple PA, Crowcroft NS, Miller E, George RC, Harrison TG. 2004. Laboratory diagnosis of pertussis infections: the role of PCR and serology. J Med Microbiol 53: 519–525. http://dx.doi.org/10.1099/jmm.0.45624-0.
87. Gullsby K, Hallander HO, Bondeson K. 2007. Performance of Bordetella pertussis IS481 real-time PCR in a vaccine trial setting. APMIS 115: 1370–1375. http://dx.doi.org/10.1111/j.1600-0463.2007.00774.x.
88. Knorr L, Fox JD, Tilley PA, Ahmed-Bentley J. 2006. Evaluation of real-time PCR for diagnosis of Bordetella pertussis infection. BMC Infect Dis 6:62. http://dx.doi.org/10.1186/1471-2334-6-62.
89. Poddar SK. 2004. Rapid detection of Bordetella pertussis by real-time PCR using SYBR green I and a LightCycler instrument. J Clin Lab Anal 18:265–270. http://dx.doi.org/10.1002/jcla.20035.
90. van der Zee A, Agterbeerg C, Peeters M, Schellekens J, Mooi FR. 1993. Polymerase chain reaction assay for pertussis: simultaneous detection and discrimination of Bordetella pertussis and Bordetella parapertussis. J Clin Microbiol 31:2134–2140.
91. Cloud JL, Hymas WC, Turlak A, Croft A, Reischl U, Daly JA, Carroll KC. 2003. Description of a multiplex Bordetella pertussis and Bordetella parapertussis LightCycler PCR assay with inhibition control. Diagn Microbiol Infect Dis 46:189–195. http://dx.doi.org/10.1016/S0732-8893(03)00045-2.
92. Sloan LM, Hopkins MK, Mitchell PS, Vetter EA, Rosenblatt JE, Harmsen WS, Cockerill FR, Patel R. 2002. Multiplex LightCycler PCR assay for detection and differentiation of Bordetella pertussis and Bordetella parapertussis in nasopharyngeal specimens. J Clin Microbiol 40:96–100. http://dx.doi.org/10.1128/JCM.40.1.96-100.2002.
93. Grogan JA, Logan C, O’Leary J, Rush R, O’Sullivan N. 2011. Real-time PCR-based detection of Bordetella pertussis and Bordetella parapertussis in an Irish paediatric population. J Med Microbiol 60:722–729. http://dx.doi.org/10.1099/jmm.0.030049-0.
94. Kösters K, Riffelmann M, Wirsing von Konig CH. 2001. Evaluation of a real-time PCR assay for detection of Bordetella pertussis and B. parapertussis in clinical samples. J Med Microbiol 50:436–440.
95. Lind-Brandberg L, Welinder-Olsson C, Lagergard T, Taranger J, Trollfors B, Zackrisson G. 1998. Evaluation of PCR for diagnosis of Bordetella pertussis and Bordetella parapertussis infections. J Clin Microbiol 36:679–683.
96. Ménard A, Lehours P, Sarlangue J, Bébéar C, Mégraud F, de Barbeyrac B. 2007. Development of a real-time PCR for the identification of Bordetella pertussis and Bordetella parapertussis. Clin Microbiol Infect 13: 419–423. http://dx.doi.org/10.1111/j.1469-0691.2006.01659.x.
97. Müller FM, Heininger U, Schnitzler N, Kockelkorn P, Cloot O, Lorenz C, Haase G. 1998. Discrimination of Bordetella parapertussis and Bordetella pertussis organisms from clinical isolates by PCR using biotinlabelled oligonucleotide probes. Mol Cell Probes 12:213–217. http://dx.doi.org/10.1006/mcpr.1998.0173.
98. Reference deleted.
99. Tatti KM, Sparks KN, Boney KO, Lucia Tondella M. 2011. Novelmultitarget real-time PCR assay for rapid detection of Bordetella species in clinical specimens. J Clin Microbiol 49:4059–4066. http://dx.doi.org/10.1128/JCM.00601-11.
100. Templeton KE, Scheltinga SA, van der Zee A, Diederen BMW, Kruijssen AM, Goossens H, Kuijper E, Claas ECJ. 2003. Evaluation of real-time PCR for detection of and discrimination between Bordetella pertussis, Bordetella parapertussis, and Bordetella holmesii for clinical diagnosis. J Clin Microbiol 41:4121–4126. http://dx.doi.org/10.1128/JCM.41.9.4121-4126.2003.
101. Xu Y, Xu Y, Hou Q, Yang R, Zhang S. 2010. Triplex real-time PCR assay for detection and differentiation of Bordetella pertussis and Bordetella parapertussis. APMIS 118:685–691. http://dx.doi.org/10.1111/j.1600-0463.2010.02644.x.
102. Birkebaek NH, Heron I, Skjodt K. 1994. Bordetella pertussis diagnosed by polymerase chain reaction. APMIS 102:291–294. http://dx.doi.org/10.1111/j.1699-0463.1994.tb04878.x.
103. Loeffelholz MJ, Thompson CJ, Long KS, Gilchrist MJR. 2000. Detection of Bordetella holmesii using Bordetella pertussis IS481 PCR assay. J Clin Microbiol 38:467.
104. Register KB, Sanden GN. 2006. Prevalence and sequence variants of IS481 in Bordetella bronchiseptica: implications for IS481-based detection of Bordetella pertussis. J Clin Microbiol 44:4577–4583. http://dx.doi.org/10.1128/JCM.01295-06.
105. Reischl U, Lehn N, Sanden GN, Loeffelholz MJ. 2001. Real-time PCR assay targeting IS481 of Bordetella pertussis and molecular basis for detecting Bordetella holmesii. J Clin Microbiol 39:1963–1966. http://dx.doi.org/10.1128/JCM.39.5.1963-1966.2001.
106. Tizolova A, Guiso N, Guillot S. 2013. Insertion sequences shared by Bordetella species and implications for the biological diagnosis of pertussis syndrome. Eur J Clin Microbiol Infect Dis 32:89–96. http://dx.doi.org/10.1007/s10096-012-1718-3.
107. Afonina I, Metcalf M, Mills A, Mahoney W. 2008. Evaluation of 5=-MGB hybridization probes for detection of Bordetella pertussis and Bordetella parapertussis using different real-time PCR instruments. Diagn Microbiol Infect Dis 60:429–432. http://dx.doi.org/10.1016/j.diagmicrobio.2007.10.019.
108. He Q, Schmidt-Schläpfer G, Just M, Matter HC, Nikkari S, Viljanen MK, Mertsola J. 1996. Impact of polymerase chain reaction on clinical pertussis: Finnish and Swiss experiences. J Infect Dis 174:1288–1295.http://dx.doi.org/10.1093/infdis/174.6.1288.
109. Reizenstein E, Johansson B, Mardin L, Abens J, Möllby R, Hallander HO. 1993. Diagnostic evaluation of polymerase chain reaction discriminative for Bordetella pertussis, B. parapertussis, and B. bronchiseptica. Diagn Microbiol Infect Dis 17:185–191. http://dx.doi.org/10.1016/0732-8893(93)90094-N.
110. Schmidt-Schläpfer G, Liese JG, Porter F, Stojanov S, Just M, Belohradsky BH. 1997. Polymerase chain reaction (PCR) compared with conventional identification in culture for detection of Bordetella pertussis in 7153 children. Clin Microbiol Infect 3:462–467. http://dx.doi.org/10.1111/j.1469-0691.1997.tb00283.x.
111. Fry NK, Duncan J, Wagner K, Tzivra O, Doshi N, Litt DJ, Crowcroft N, Miller E, George RC, Harrison TG. 2009. Role of PCR in the diagnosis of pertussis infection in infants: 5 years’ experience of provision of a same-day real-time PCR service in England and Wales from 2002 to 2007. J Med Microbiol 58:1023–1029. http://dx.doi.org/10.1099/jmm.0.009878-0.
112. André P, Caro V, Njamkepo E, Wendelboe AM, Van Rie A, Guiso N. 2008. Comparison of serological and real-time PCR assays to diagnose Bordetella pertussis infection in 2007. J Clin Microbiol 46:1672–1677. http://dx.doi.org/10.1128/JCM.02187-07.
113. Nikbin VS, Shahcheraghi F, Lotfi MN, Zahraei SM, Parzadeh M. 2013. Comparison of culture and real-time PCR for detection of Bordetella pertussis isolated from patients in Iran. Iran J Microbiol 5:209–214.
114. Qin X, Galanakis E, Martin ET, Englund JA. 2007. Multitarget PCR for diagnosis of pertussis and its clinical implications. J Clin Microbiol 45: 506–511. http://dx.doi.org/10.1128/JCM.02042-06.
115. Rodgers L, Martin SW, Cohn A, Budd J, Marcon M, Terranella A, Mandal S, Salamon D, Leber A, Tondella ML, Tatti K, Spicer K, Emanuel A, Koch E, McGlone L, Pawloski L, Lemaile-Williams M, Tucker N, Iyer R, Clark TA, Diorio M. 2013. Epidemiologic and laboratory features of a large outbreak of pertussis-like illnesses associated with cocirculating Bordetella holmesii and Bordetella pertussis— Ohio, 2010–2011. Clin Infect Dis 56:322–331. http://dx.doi.org/10.1093/cid/cis888.
116. Roorda L, Buitenwerf J, Ossewaarde JM, van der Zee A. 2011. A real-time PCR assay with improved specificity for detection and discrimination of all clinically relevant Bordetella species by the presence of distribution of three insertion sequence elements. BMC Res Notes 4:11. http://dx.doi.org/10.1186/1756-0500-4-11.
117. Spicer KB, Salamon D, Cummins C, Leber A, Rodgers LE, Marcon MJ. 2014. Occurrence of three Bordetella species during an outbreak of cough illness in Ohio: epidemiology, clinical features, laboratory findings, and antimicrobial susceptibility. Pediatr Infect Dis J 3:e162–e167.
118. Tatti KM, Wu KH, Tondella ML, Cassiday PK, Cortese MM, Wilkins PP, Sanden GN. 2008. Development and evaluation of dualtarget real-time polymerase chain reaction assays to detect Bordetella spp. Diagn Microbiol Infect Dis 61:264–272. http://dx.doi.org/10.1016/j.diagmicrobio.2008.02.017.
119. Qin X, Turgeon DK, Ingersoll BP, Monsaas PW, Lemoine CJ, Tsosie T, Stapp LO, Abe PM. 2002. Bordetella pertussis PCR: simultaneous targeting of signature sequences. Diagn Microbiol Infect Dis 43:269–275. http://dx.doi.org/10.1016/S0732-8893(02)00405-4.
120. Kallonen T, Mertsola J, Mooi FR, He Q. 2012. Rapid detection of the recently emerged Bordetella pertussis strains with the ptxP3 pertussis toxin promoter allele by real-time PCR. Clin Microbiol Infect 18:E377–E379. http://dx.doi.org/10.1111/j.1469-0691.2012.04000.x.
121. Mooi FR, van Loo IHM, van Gent M, He Q, Heuvelman CJ, Bart MJ, de Greeff SC, Diavatopoulos DA, Teunis PF, Nagelkerke NJ, Mertsola J. 2009. Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerg Infect Dis 15:1206–1213. http://dx.doi.org/10.3201/eid1508.081511.
122. Nygren M, Reizenstein E, Ronaghi M, Lundeberg J. 2000. Polymorphism in the pertussis toxin promoter region affecting the DNA-based diagnosis of Bordetella infection. J Clin Microbiol 38:55–60.
123. Houard S, Hackel C, Herzog A, Bollen A. 1989. Specific identification of Bordetella pertussis by the polymerase chain reaction. Res Microbiol 140:477–487. http://dx.doi.org/10.1016/0923-2508(89)90069-7.
124. Mastrantonio P, Stefanelli P, Giuliano M. 1996. Polymerase chain reaction for the detection of Bordetella pertussis in clinical nasopharyngeal aspirates. J Med Microbiol 44:261–266. http://dx.doi.org/10.1099/00222615-44-4-261.
125. Douglas E, Coole JG, Parton R, McPheat W. 1993. Identification of Bordetella pertussis in nasopharyngeal swabs by PCR amplification of a region of the adenylate cyclase gene. J Med Microbiol 38:140–144. http://dx.doi.org/10.1099/00222615-38-2-140.
126. Mäkinen J, Viljanen MK, Mertsola J, Arvilommi H, He Q. 2001. Rapid identification of Bordetella pertussis pertactin gene variants using Light- Cycler real-time polymerase chain reaction combined with melting curve analysis and gel electrophoresis. Emerg Infect Dis 7:952–958. http://dx.doi.org/10.3201/eid0706.010606.
127. Vincart B, De Mendonça R, Rottiers S, Vermeulen F, Struelens MJ, Denis O. 2007. A specific real-time PCR assay for the detection of Bordetella pertussis. J Med Microbiol 56:918–920. http://dx.doi.org/10.1099/jmm.0.46947-0.
128. Walsh P, Overmeyer C, Kimmel L, Feola M, Pusavat J, Nguyen TA, Kuan S, Emery K, Rosengreen M, Mordechai E, Adelson ME. 2008. Prevalence of Bordetella pertussis and Bordetella parapertussis in samples submitted for RSV screening. West J Emerg Med 9:135–140.
129. Li ZM, Jansen DL, Finn TM, Halperin SA, Kasina A, O’Connor SP, Aoyama T, Manclark CR, Brennan MJ. 1994. Identification of Bordetella pertussis infection by shared-primer PCR. J Clin Microbiol 32:783–789.
130. Probert WS, Ely J, Schrader K, Atwell J, Nossoff A, Kwan S. 2008. Identification and evaluation of new target sequences for specific detection of Bordetella pertussis by real-time PCR. J Clin Microbiol 46:3228–3231. http://dx.doi.org/10.1128/JCM.00386-08.
131. Register KB, Nicholson TL, Guthrie JL. 2010. Evaluation of specificity of BP3385 for Bordetella pertussis detection. J Clin Microbiol 48:3334–3337. http://dx.doi.org/10.1128/JCM.00945-10.
132. Brinig MM, Cummings CA, Sanden GN, Stefanelli P, Lawrence A, Relman DA. 2006. Significant gene order and expression differences in Bordetella pertussis despite limited gene content variation. J Bacteriol 188:2375–2382. http://dx.doi.org/10.1128/JB.188.7.2375-2382.2006.
133. Heikkinen E, Kallonen T, Saarinen L, Sara R, King AJ, Mooi FR, Soini JT, Mertsola J, He Q. 2007. Comparative genomics of Bordetella per-tussis reveals progressive gene loss in Finnish strains. PLoS One 2:e904. http://dx.doi.org/10.1371/journal.pone.0000904.
134. King AJ, van Gorkom T, Pennings JL, van der Heide HG, He Q, Diavatopoulos D, Heuvelman K, van Gent M, van Leeuwen K, Mooi FR. 2008. Comparative genomic profiling of Dutch clinical Bordetella pertussis isolates using DNA microarrays: identification of genes absent from epidemic strains. BMC Genomics 9:311. http://dx.doi.org/10.1186/1471-2164-9-311.
135. Hassan F, Hays L, Bell J, Selvarangan R. 2014. Evaluation of 3 analytespecific reagents for detection of Bordetella pertussis and Bordetella parapertussis in clinical specimens. Diagn Microbiol Infect Dis 80:181–184. http://dx.doi.org/10.1016/j.diagmicrobio.2014.08.004.
136. Lanotte P, Plouzeau C, Burucoa C, Grélaud C, Guillot S, Guiso N, Garnier F. 2011. Evaluation of four commercial real-time PCR assays for detection of Bordetella spp. in nasopharyngeal aspirates. J Clin Microbiol 49:3943–3946. http://dx.doi.org/10.1128/JCM.00335-11.
137. Kenicer J, Hardie A, Hamilton F, Gadsby N, Templeton K. 2014. Comparative evaluation of the Diagenode multiplex PCR assay on the BD Max system versus a routine in-house assay for detection of Bordetella pertussis. J Clin Microbiol 52:2668–2670. http://dx.doi.org/10.1128/JCM.00212-14.
138. Koidl C, Bozic M, Burmeister A, Hess M, Marth E, Kessler HH. 2007. Detection and differentiation of Bordetella spp. by real-time PCR. J Clin Microbiol 45:347–350. http://dx.doi.org/10.1128/JCM.01303-06.
139. Cohen-Bacrie S, Bertin F, Gassiot AS, Prère MF. 2010. Rapid molecular genetic assay for direct identification of Bordetella from patients specimens. Pathol Biol 58:52–54. http://dx.doi.org/10.1016/j.patbio.2009.07.005.
140. Pillet S, Lardeux M, Dina J, Grattard F, Verhoeven P, Le Goff J, Vabret A, Pozzetto B. 2013. Comparative evaluation of six commercialized multiplex PCR kits for the diagnosis of respiratory infections. PLoS One 8:e72174. http://dx.doi.org/10.1371/journal.pone.0072174.
141. Kallonen T, Grondahl-Yli-Hannuksela K, Elomaa A, Lutynska A, Fry NK, Mertsola J, He Q. 2011. Differences in the genomic content of Bordetella pertussis isolates before and after introduction of pertussis vaccines in four European countries. Infect Genet Evol 11:2034–2042. http://dx.doi.org/10.1016/j.meegid.2011.09.012.
142. Lievano FA, Reynolds MA, Waring AL, Ackelsberg J, Bisgard KM, Sanden GN, Guris D, Golaz A, Bopp DJ, Limberger RJ, Smith PF. 2002. Issues associated with and recommendations for using PCR to detect outbreaks of pertussis. J Clin Microbiol 40:2801–2805. http://dx.doi.org/10.1128/JCM.40.8.2801-2805.2002.
143. Weber DJ, Miller MB, Brooks RH, Brown VM, Rutala WA. 2010. Healthcare worker with “pertussis”: consequences of a false-positive polymerase chain reaction test result. Infect Control Hosp Epidemiol 31:306–307. http://dx.doi.org/10.1086/650760.
144. Taranger J, Trollfors B, Lind L, Zackrisson G, Beling-Holmquist K. 1994. Environmental contamination leading to false-positive polymerase chain reaction for pertussis. Pediatr Infect Dis J 13:936–937.
145. Salimnia H, Lephart PR, Asmar BI, Prebelich D, Paulson E, Fairfax MR. 2012. Aerosolized vaccine as an unexpected source of false-positive Bordetella pertussis PCR results. J Clin Microbiol 50:472–474. http://dx.doi.org/10.1128/JCM.01250-11.
146. Meade BD, Bollen A. 1994. Recommendation for use of the polymerase chain reaction in the diagnosis of Bordetella pertussis infections. J Med Microbiol 41:51–55. http://dx.doi.org/10.1099/00222615-41-1-51.
147. Herwegh S, Carnoy C, Wallet F, Loïez C, Courcol RJ. 2005. Development and use of an internal positive control for detection of Bordetella pertussis by PCR. J Clin Microbiol 43:2462–2464. http://dx.doi.org/10.1128/JCM.43.5.2462-2464.2005.
148. Koidl C, Bozic M, Berg J, Stöcher M, Mühlbauer G, Marth E, Kessler HH. 2005. Addition of a homologous internal control to a real-time PCR assay for detection of Bordetella pertussis. Clin Chem 51:2404–2406. http://dx.doi.org/10.1373/clinchem.2005.052183.
149. Müller FM, Schnitzler N, Cloot O, Kockelkorn P, Haase G, Li Z. 1998. The rationale and method for constructing internal control DNA used in pertussis polymerase chain reaction. Diagn Microbiol Infect Dis 31:517–523. http://dx.doi.org/10.1016/S0732-8893(98)00043-1.
150. Fry NK, Tzivra O, Duncan J, Doshi N, Harrison TG. 2004. Consensus real-time PCR assay for Bordetella pertussis including an internal process control provides specific diagnosis, rapid turnaround time, high diagnostic yield and enhanced surveillance. Clin Microbiol Infect 10(Suppl 3):7.
151. Lingappa JR, Lawrence W, West-Keefe S, Gautom R, Cookson BT. 2002. Diagnosis of community-acquired pertussis infection: comparison of both culture and fluorescent-antibody assays with PCR detection using electrophoresis or dot blot hybridization. J Clin Microbiol 40:2908–2912. http://dx.doi.org/10.1128/JCM.40.8.2908-2912.2002.
152. Burd EM. 2010. Validation of laboratory-developed molecular assays for infectious diseases. Clin Microbiol Rev 23:550–576. http://dx.doi.org/10.1128/CMR.00074-09.
153. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, Vandesompele J, Wittwer CT. 2009. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55:611–622. http://dx.doi.org/10.1373/clinchem.2008.112797.
154. Papenburg J, Fontela P. 2009. What is the significance of a high cycle threshold positive IS481 PCR for Bordetella pertussis? Pediatr Infect Dis J 28:1143. http://dx.doi.org/10.1097/INF.0b013e3181bd4e1f.
155. Guthrie JL, Seah C, Brown S, Tang P, Jamieson F, Drews SJ. 2008. Use of Bordetella pertussis BP3385 to establish a cutoff value for an IS481-targeted real-time PCR assay. J Clin Microbiol 46:3798–3799. http://dx.doi.org/10.1128/JCM.01551-08.
156. Edelman K, Nikkari S, Ruuskanen O, He Q, Viljanen M, Mertsola J. 1996. Detection of Bordetella pertussis by polymerase chain reaction and culture in the nasopharynx of erythromycin-treated infants with pertussis. Pediatr Infect Dis J 15:54–57. http://dx.doi.org/10.1097/00006454-199601000-00012.
157. Muyldermans G, Soetens O, Antoine M, Bruisten S, Vincart B, Doucet K, Populaire F, Fry NK, Olcen P, Scheftel JM, Senterre JM, van der Zee A, Riffelmann M, Pierard D, Lauwers S. 2005. External quality assessment for molecular detection of Bordetella pertussis in European laboratories. J Clin Microbiol 43:30–35. http://dx.doi.org/10.1128/JCM.43.1.30-35.2005.
158. Tatti KM, Martin SW, Boney KO, Brown K, Clark TA, Tondella ML. 2013. Qualitative assessment of pertussis diagnostics in United States laboratories. Pediatr Infect Dis J 32:942–945. http://dx.doi.org/10.1097/INF.0b013e3182947ef8.
159. Dalby T, Fry NK, Krogfelt KA, Jensen JS, He Q. 2013. Evaluation of PCR methods for the diagnosis of pertussis by the European surveillance network for vaccine-preventable diseases (EUVAC.NET). J Clin Microbiol Infect Dis 32:1285–1289. http://dx.doi.org/10.1007/s10096-013-1874-0.
160. Williams MM, Taylor TH, Jr, Warshauer DM, Martin MD, Valley AM, Tondella ML. 2015. Harmonization of Bordetella pertussis realtime PCR diagnostics in the United States in 2012. J Clin Microbiol 53:118–123. http://dx.doi.org/10.1128/JCM.02368-14.
161. Burgos-Rivera B, Lee AD, Bowden KE, Faulkner AE, Seaton BL, Lembke BD, Cartwright CP, Martin SW, Tondella ML. 2015. Evaluation of level of agreement in Bordetella species identification in three U.S. laboratories during a period of increased pertussis. J Clin Microbiol 53: 1842–1847. http://dx.doi.org/10.1128/JCM.03567-14.
162. Ghanaie RM, Karimi A, Sadeghi H, Esteghamti A, Falah F, Armin S, Fahimzad A, Shamshiri A, Kahbazi M, Shiva F. 2010. Sensitivity and specificity of the World Health Organization pertussis clinical case definition. Int J Infect Dis 14:e1072–e1075. http://dx.doi.org/10.1016/j.ijid.2010.07.005.
163. Patriarca PA, Biellik RJ, Sanden G, Burstyn DG, Mitchell PD, Silverman PR, Davis JP, Manclark CR. 1988. Sensitivity and specificity of clinical case definitions for pertussis. Am J Public Health 78:833–836. http://dx.doi.org/10.2105/AJPH.78.7.833.
164. Strebel PM, Cochi SL, Farizo KM, Payne BJ, Hanauer SD, Baughman AL. 1993. Pertussis in Missouri: evaluation of nasopharyngeal culture, direct fluorescent antibody testing, and clinical case definitions in the diagnosis of pertussis. Clin Infect Dis 16:276–285. http://dx.doi.org/10.1093/clind/16.2.276.
165. Bordet J, Gengou O. 1906. Le microbe de la coqueluche. Ann Inst Pasteur 20:731–741.
166. Bordet J, Gengou O. 1907. Note complémentaire sur le microbe de la coqueluche. Ann Inst Pasteur 21:720–726.
167. Weichsel M, Douglas HS. 1937. Complement fixation tests in pertussis. J Clin Invest 16:15–22. http://dx.doi.org/10.1172/JCI100833.
168. Donald AB. 1938. The diagnosis of whooping-cough. Br Med J 2:613–618. http://dx.doi.org/10.1136/bmj.2.4054.613.
169. Evans DG, Maitland HB. 1939. Agglutination as a diagnostic test for whooping cough. J Pathol 48:468–470. http://dx.doi.org/10.1002/path.1700480219.
170. Kendrick PL, Gottshall RY, Anderson HD, Volk VK, Bunney WE, Top FH. 1969. Pertussis agglutinins in adults. Public Health Rep 84:9–15. http://dx.doi.org/10.2307/4593487.
171. British Medical Journal. 1970. Diagnosis of whooping cough: comparison of serological tests with isolation of Bordetella pertussis. A combined Scottish study. Br Med J 4:637–639.
172. Bradstreet CMP, Tannahill AJ, Edwards JMB, Benson PF. 1972. Detection of Bordetella pertussis antibodies in human sera by complementfixation and immunofluorescence. J Hyg (Cambridge) 70:75–83. http://dx.doi.org/10.1017/S0022172400022117.
173. Macaulay ME. 1979. The serological diagnosis of whooping cough. J Hyg (Cambridge) 83:95–102. http://dx.doi.org/10.1017/S0022172400025857.
174. Macaulay ME. 1981. The IgM and IgG response to Bordetella pertussis vaccination and infection. J Med Microbiol 14:1–7. http://dx.doi.org/10.1099/00222615-14-1-1.
175. Manclark MC, Meade BD, Burstyn DG. 1986. Serological response to Bordetella pertussis, p 388–394. In Rose NR, Friedman H, Fayhey JL (ed), Manual of clinical laboratory immunology, 3rd ed. American Society for Microbiology, Washington, DC.
176. Guiso N, Grimprel E, Anjak I, Bégué P. 1993. Western blot analysis of antibody responses of young infants to pertussis infection. Eur J Clin Microbiol Infect Dis 12:596–600. http://dx.doi.org/10.1007/BF01973637.
177. Mink CM, O’Brien CH, Wassilak S, Deforest A, Meade BD. 1994. Isotype and antigen specificity of pertussis agglutinins following wholecell pertussis vaccination and infection with Bordetella pertussis. Infect Immun 62:1118–1120.
178. Heininger U, Stehr K, Schmitt-Grohe S, U¨ berall M, Lorenz C, Rost R, Cherry JD. 1995. Der Mikroagglutinationstest-ein einfaches und sensitives Verfahren zur Serodiagnostik von Pertussisinfektionen. Klin Paediatr 207:277–280. http://dx.doi.org/10.1055/s-2008-1046551.
179. Aoyama T, Kato T, Takeuchi Y, Kato K, Morokuma K, Hirai T. 1997. Simple, speedy, sensitive, and specific serodiagnosis of pertussis by using a particle agglutination test. J Clin Microbiol 35:1859–1861.
180. Granström M, Lindberg AA, Askelöf P, Hederstedt B. 1982. Detection of antibodies in human serum against the fimbrial haemagglutinin of Bordetella pertussis by enzyme-linked immunosorbent assay. J Med Microbiol 15:85–96. http://dx.doi.org/10.1099/00222615-15-1-85.
181. Lawrence AJ, Paton JC. 1987. Efficacy of enzyme-linked immunosorbent assay for rapid diagnosis of Bordetella pertussis infection. J Clin Microbiol 25:2102–2104.
182. Long SS, Welkon CJ, Clark JL. 1990. Widespread silent transmission of pertussis in families: antibody correlates of infection and symptomatology. J Infect Dis 161:480–486. http://dx.doi.org/10.1093/infdis/161.3.480.
183. Mertsola J, Ruuskanen O, Kuronen T, Viljanen MK. 1983. Serologic diagnosis of pertussis: comparison of enzyme-linked immunosorbent assay and bacterial agglutination. J Infect Dis 147:252–257. http://dx.doi.org/10.1093/infdis/147.2.252.
184. Hewlett EL, Sauer KT, Myers GA, Cowell JL, Guerrant RL. 1983. Induction of a novel morphological response in Chinese hamster ovary cells by pertussis toxin. Infect Immun 40:1198–1203.
185. Gillenius P, Jäätmaa E, Askelöf P, Granström M, Tiru M. 1985. The standardization of an assay for pertussis toxin and antitoxin in microplate culture of Chinese hamster ovary cells. J Biol Stand 13:61–66. http://dx.doi.org/10.1016/S0092-1157(85)80034-2.
186. Granström G, Wretlind B, Salenstedt CR, Granström M. 1988. Evaluation of serologic assays for diagnosis of whooping cough. J Clin Microbiol 26:1818–1823.
187. Hallander HO, Storsaeter J, Möllby R. 1991. Evaluation of serology and nasopharyngeal cultures for diagnosis of pertussis in a vaccine efficacy trial. J Infect Dis 163:1046–1054. http://dx.doi.org/10.1093/infdis/163.5.1046.
188. Trollfors B, Krantz I, Sigurs N, Taranger J, Zackrisson G, Roberson R. 1988. Toxin-neutralizing antibodies in patients with pertussis, as determined by an assay using Chinese hamster ovary cells. J Infect Dis 158: 991–995. http://dx.doi.org/10.1093/infdis/158.5.991.
189. Mertsola J, Ruuskanen O, Kuronen T, Meurman O, Viljanen MK. 1990. Serologic diagnosis of pertussis: evaluation of pertussis toxin and other antigens in enzyme-linked immunosorbent assay. J Infect Dis 161: 966–971. http://dx.doi.org/10.1093/infdis/161.5.966.
190. Novotny P, Macaulay ME, Hart TC, Skvaril F. 1991. Analysis of antibody profiles in children with whooping cough. Dev Biol Stand 73: 267–273.
191. Watanabe M, Connelly B, Weiss AA. 2006. Characterization of serological responses to pertussis. Clin Vaccine Immunol 13:341–348. http://dx.doi.org/10.1128/CVI.13.3.341-348.2006.
192. Granström M, Granström G, Lindfors A, Askelöf P. 1982. Serologic diagnosis of whooping cough by an enzyme-linked immunosorbent assay using fimbrial hemagglutinin as antigen. J Infect Dis 146:741–745.http://dx.doi.org/10.1093/infdis/146.6.741.
193. Zackrisson G, Arminjon F, Krantz I, Lagergård T, Sigurs N, Taranger J, Trollfors B. 1988. Serum antibody response to filamentous hemagglutinin in patients with clinical pertussis measured by an enzyme-linked immunosorbent assay. Eur J Clin Microbiol Infect Dis 7:764–770. http://dx.doi.org/10.1007/BF01975044.
194. Zackrisson G, Krantz I, Lagergård T, Larsson P, Sekura R, Sigurs N, Taranger J, Trollfors B. 1988. Antibody response to pertussis toxin in patients with clinical pertussis measured by enzyme-linked immunosorbent assay. Eur J Clin Microbiol Infect Dis 7:149–154. http://dx.doi.org/10.1007/BF01963068.
195. Horby P, Macintyre CR, McIntyre PB, Gilbert GL, Staff M, Hanlon M, Heron LG, Cagney M, Bennett C. 2005. A boarding school outbreak of pertussis in adolescents: value of laboratory diagnostic methods. Epidemiol Infect 133:229–236. http://dx.doi.org/10.1017/S0950268804003401.
196. May ML, Doi SA, King D, Evans J, Robson JM. 2012. Prospective evaluation of an Australian pertussis toxin IgG and IgA enzyme immunoassay. Clin Vaccine Immunol 19:190-197. http://dx.doi.org/10.1128/CVI.05430-11.
197. Nagel J, de Graaf S, Schijf-Evers D. 1985. Improved serodiagnosis of whooping cough caused by Bordetella pertussis by determination of IgG anti-LPF antibody levels. Dev Biol Stand 61:325–330.
198. Wirsing von König CH, Schmitt HJ. 1996. Epidemiologic aspects and diagnostic criteria for a protective efficacy field trial of a pertussis vaccine. J Infect Dis 174:S281–S286. http://dx.doi.org/10.1093/infdis/174.Supplement_3.S281.
199. van der Zee A, Agterberg C, Peeters M, Mooi F, Schellekens J. 1996. A clinical validation of Bordetella pertussis and Bordetella parapertussis polymerase chain reaction: comparison with culture and serology using samples from patients with suspected whooping cough from a highly immunized population. J Infect Dis 174:89–96. http://dx.doi.org/10.1093/infdis/174.1.89.
200. Deen JL, Mink CA, Cherry JD, Christenson PD, Pineda EF, Lewis K, Blumberg DA, Ross LA. 1995. Household contact study of Bordetella pertussis infections. Clin Infect Dis 21:1211–1219. http://dx.doi.org/10.1093/clinids/21.5.1211.
201. Giammanco A, Taormina S, Genovese M, Mangiaracina G, Giammanco G, Chiarini A. 1997. Serological responses to infection with B pertussis. Dev Biol Stand 89:213–220.
202. Heininger U, Cherry JD, Stehr K. 2004. Serologic response and antibody- titer decay in adults with pertussis. Clin Infect Dis 38:591–594. http://dx.doi.org/10.1086/381439.
203. Burstyn DG, Baraff LJ, Peppler MS, Leake RD, St Geme J, Manclark CR. 1983. Serological response to filamentous hemagglutinin and lymphocytosis-promoting toxin of Bordetella pertussis. Infect Immun 41: 1150–1156.
204. Hendrikx LH, O¨ ztürk K, de Rond LG, de Greeff SC, Sanders EA, Berbers GA, Buisman AM. 2011. Serum IgA responses against pertussis proteins in infected and Dutch wP or aP vaccinated children: an additional role in pertussis diagnostics. PLoS One 6:e27681. http://dx.doi.org/10.1371/journal.pone.0027681.
205. Nagel J, Poot-Scholtens EJ. 1983. Serum IgA antibody to Bordetella pertussis as an indicator of infection. J Med Microbiol 16:417–426. http://dx.doi.org/10.1099/00222615-16-4-417.
206. Stehr K, Cherry JD, Heininger U, Schmitt-Grohé S, Uberall M, Laussucq S, Eckhardt T, Meyer M, Engelhardt R, Christenson P. 1998. A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccine. Pediatrics 101:1–11. http://dx.doi.org/10.1542/peds.101.1.1.
207. Le T, Cherry JD, Chang SJ, Knoll MD, Lee ML, Barenkamp S, Bernstein D, Edelman R, Edwards KM, Greenberg D, Keitel W, Treanor J, Ward JI, APERT Study. 2004. Immune responses and anti-body decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study. J Infect Dis 190:535–544. http://dx.doi.org/10.1086/422035.
208. Isacson J, Trollfors B, Taranger J, Lagergård T. 1995. Acquisition of IgG serum antibodies against two Bordetella antigens (filamentous hemagglutinin and pertactin) in children with no symptoms of pertussis. Pediatr Infect Dis J 14:517–521. http://dx.doi.org/10.1097/00006454-199506000-00009.
209. Trollfors B, Lagergård T, Gunnarsson E, Taranger J. 2003. Determination of pertactin IgG antibodies for the diagnosis of pertussis. Clin Microbiol Infect 9:585–589. http://dx.doi.org/10.1046/j.1469-0691.2003.00552.x.
210. Hallander HO, Ljungman M, Jahnmatz M, Storsaeter J, Nilsson L, Gustafsson L. 2009. Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti-Fim2/3 antibodies after vaccination and infection. APMIS 117:660–671. http://dx.doi.org/10.1111/j.1600-0463.2009.02521.x.
211. Cherry JD, Xing DXL, Newland P, Patel K, Heininger U, Corbel MJ. 2004. Determination of serum antibody to Bordetella pertussis adenylate cyclase toxin in vaccinated and unvaccinated children and in children and adults with pertussis. Clin Infect Dis 38:502–507. http://dx.doi.org/10.1086/381204.
212. Arciniega JL, Hewlett EL, Johnson FD, Deforest A, Wassilak SGF, Onorato IM, Manclark CR, Burns DL. 1991. Human serological response to envelope-associated proteins and adenylate cyclase toxin of Bordetella pertussis. J Infect Dis 163:135–142. http://dx.doi.org/10.1093/infdis/163.1.135.
213. Fazekas S, Webster RG. 1966. Disquisitions on original antigenic sin. I. Evidence in man. J Exp Med 124:331–345.
214. Goodman YE, Wort AJ, Jackson FL. 1981. Enzyme-linked immunosorbent assay for detection of pertussis immunoglobulin A in nasopharyngeal secretions as an indicator of recent infection. J Clin Microbiol 13: 286–292.
215. Viljanen MK, Ruuskanen O, Granberg C, Salmi TT. 1982. Serological diagnosis of pertussis: IgM, IgA and IgG antibodies against Bordetella pertussis measured by enzyme-linked immunosorbent assay (ELISA). Scand J Infect Dis 14:117–122. http://dx.doi.org/10.3109/inf.1982.14.issue-2.08.
216. Barenkamp SJ, Leininger E. 1992. Cloning, expression, and DNA sequence analysis of genes encoding nontypeable Haemophilus influenzae high-molecular-weight surface-exposed proteins related to filamentous hemagglutinin of Bordetella pertussis. Infect Immun 60:1302–1313.
217. Trollfors B, Burman L, Lagergård T, Leinonen M, Taranger J. 1996. No cross-reactivity with filamentous hemagglutinin of Bordetella pertussis in sera from patients with nontypable Haemophilus influenzae pneumonia. Pediatr Infect Dis J 15:558–559.
218. Vincent JM, Cherry JD, Nauschuetz WF, Lipton A, Ono CM, Costello CN, Sakaguchi LK, Hsue G, Jackson LA, Tachdjian R, Cotter PA, Gornbein JA. 2000. Prolonged afebrile nonproductive cough illnesses in American soldiers in Korea: a serological search for causation. Clin Infect Dis 30:534–539. http://dx.doi.org/10.1086/313707.
219. Carlsson RM, Claesson BA, Lagergärd Trollfors B. 1999. Acquisition of serum antibodies against filamentous hemagglutinin and pertactin unrelated to Bordetella pertussis infection. Clin Microbiol Infect 5:709–712. http://dx.doi.org/10.1111/j.1469-0691.1999.tb00520.x.
220. Isacson J, Trollfors B, Hedvall G, Taranger J, Zackrisson G. 1995. Response and decline of serum IgG antibodies to pertussis toxin, filamentous hemagglutinin and pertactin in children with pertussis. Scand J Infect Dis 27:273–277. http://dx.doi.org/10.3109/00365549509019021.
221. Lynn F, Reed GF, Meade BD. 1996. Collaborative study for the evaluation of enzyme-linked immunosorbent assays used to measure human antibodies to Bordetella pertussis antigens. Clin Diagn Lab Immunol 3:689–700.
222. Meade BD, Deforest A, Edwards KM, Romani TA, Lynn F, O’Brien CH, Swartz CB, Reed GF, Deloria MA. 1995. Description and evaluation of serologic assays used in a multicenter trial of acellular pertussis vaccines. Pediatrics 96(Suppl):570–575.
223. Xing D, Wirsing von König CH, Newland P, Riffelmann M, Meade BD, Corbel M, Gaines-Das R. 2009. Characterization of reference materials for human antiserum to pertussis antigens by an international collaborative study. Clin Vaccine Immunol 16:303–311. http://dx.doi.org/10.1128/CVI.00372-08.
224. Reizenstein E, Hallander HO, Blackwelder WC, Kühn I, Ljungman M, Möllby R. 1995. Comparison of five calculation modes for antibody ELISA procedures using pertussis serology as a model. J Immunol Methods 183:279–290. http://dx.doi.org/10.1016/0022-1759(95)00067-K.
225. Gustafsson L, Hallander HO, Olin P, Reizenstein E, Storsaeter J. 1996. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N Engl J Med 334:349–355. http://dx.doi.org/10.1056/NEJM199602083340602.
226. Heininger U, Schmidt-Schläpfer G, Cherry JD, Stehr K. 2000. Clinical validation of a polymerase chain reaction assay for the diagnosis of pertussis by comparison with serology, culture, and symptoms during a large pertussis vaccine efficacy trial. Pediatrics 105:E31. http://dx.doi.org /10.1542/peds.105.3.e31.
227. Schmitt HJ, von König CH, Neiss A, Bogaerts H, Bock HL, Schulte- Wissermann H, Gahr M, Schult R, Folkens JU, Rauh W, Clemens R. 1996. Efficacy of acellular pertussis vaccine in early childhood after household exposure. JAMA 275:37–41.
228. Simondon F, Iteman I, Preziosi MP, Yam A, Guiso N. 1998. Evaluation of an immunoglobulin G enzyme-linked immunosorbent assay for pertussis toxin and filamentous hemagglutinin in diagnosis of pertussis in Senegal. Clin Diagn Lab Immunol 5:130–134.
229. Giammanco A, Chiarini A, Maple PA, Andrews N, Pebody R, Gay N, Olander RM, Fivet-Groyne F, Baron S, Tischer A, Swidsinski S, Schellekens J, Reizenstein E. 2003. European Sero-Epidemiology Network: standardisation of the assay results for pertussis. Vaccine 22:112–120. http://dx.doi.org/10.1016/S0264-410X(03)00514-0.
230. de Greeff SC, Teunis P, de Melker HE, Mooi FR, Notermans DW, Elvers B, Schellekens JF. 2012. Two-component cluster analysis of a large serodiagnostic database for specificity of increases of IgG antibodies against pertussis toxin in paired serum samples and of absolute values in single serum samples. Clin Vaccine Immunol 19:1452–1456. http://dx.doi.org/10.1128/CVI.00229-12.
231. Sekura RD, Fish F, Manclark CR, Meade B, Zhang YL. 1983. Pertussis toxin. Affinity purification of a new ADP-ribosyltransferase. J Biol Chem 258:14647–14651.
232. Zackrisson G, Lagergård T, Lönnroth I. 1986. An enzyme-linkedimmunosorbent assay method for detection of immunoglobulins to pertussis toxin. Acta Pathol Immunol Scand Sect C 94:227–231.
233. Kapasi A, Meade BD, Plikaytis B, Pawloski L, Martin MD, Yoder S, Rock MT, Coddens S, Haezebroeck V, Fievet-Groyne F, Bixler G, Jones C, Hildreth S, Edwards KM, Messonnier NE, Tondella ML. 2012. Comparative study of different sources of pertussis toxin (PT) as coating antigens in IgG anti-PT enzyme-linked immunosorbent assays. Clin Vaccine Immunol 19:64–72. http://dx.doi.org/10.1128/CVI.05460-11.
234. Menzies SL, Kadwad V, Pawloski LC, Lin TL, Baughman AL, Martin M, Tondella ML, Meade BD, Pertussis Assay Working Group. 2009. Development and analytical validation of an immunoassay for quantifying serum anti-pertussis toxin antibodies resulting from Bordetella pertussis infection. Clin Vaccine Immunol 16:1781–1788. http://dx.doi.org/10.1128/CVI.00248-09.
235. Greco D, Salmaso S, Mastrantonio P, Giuliano M, Tozzi AE, Anemona A, Ciofi degli Atti ML, Giammanco A, Panei P, Blackwelder WC, Klein DL, Wassilak SG. 1996. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group. N Engl J Med 334:341–348.
236. Granström G, Granström M. 1994. Effect of erythromycin treatment on antibody responses in pertussis. Scand J Infect Dis 26:453–457. http://dx.doi.org/10.3109/00365549409008619.
237. Strebel P, Nordin J, Edwards K, Hunt J, Besser J, Burns S, Amundson G, Baughman A, Wattigney W. 2001. Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995–1996. J Infect Dis 183:1353–1359. http://dx.doi.org/10.1086/319853.
238. Wirsing von König CH, Gounis D, Laukamp S, Bogaerts H, Schmitt HJ. 1999. Evaluation of a single-sample serological technique for diagnosing pertussis in unvaccinated children. Eur J Clin Microbiol Infect Dis 18:341–345. http://dx.doi.org/10.1007/PL00015016.
239. Wirsing von König CH, Postels-Multani S, Bock HL, Schmitt HJ. 1995. Pertussis in adults: frequency of transmission after household exposure. Lancet 346:1326–1329. http://dx.doi.org/10.1016/S0140-6736(95)92343-8.
240. Senzilet LD, Halperin SA, Spika JS, Alagaratnam M, Morris A, Smith B, Sentinel Health Unit Surveillance System Pertussis Working Group. 2001. Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. Clin Infect Dis 32:1691–1697. http://dx.doi.org/10.1086/320754.
241. Marchant CD, Loughlin AM, Lett SM, Todd CW, Wetterlow LH, Bicchieri R, Higham S, Etkind P, Silva E, Siber GR. 1994. Pertussis in Massachusetts, 1981–1991: incidence, serologic diagnosis, and vaccine effectiveness. J Infect Dis 169:1297–1305. http://dx.doi.org/10.1093/infdis/169.6.1297.
242. Dalby T, Petersen JW, Harboe ZB, Krogfelt KA. 2010. Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine. J Med Microbiol 59:1029–1036. http://dx.doi.org/10.1099/jmm.0.020826-0.
243. Baughman AL, Bisgard KM, Edwards KM, Guris D, Decker MD, Holland K, Meade BD, Lynn F. 2004. Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States. Clin Diagn Lab Immunol 11:1045–1053.
244. Yih WK, Lett SM, des Vignes FN, Garrison KM, Sipe PL, Marchant CD. 2000. The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989–1998. J Infect Dis 182:1409–1416. http://dx.doi.org/10.1086/315863.
245. Versteegh FGA, Mertens PLJM, de Melker HE, Roord JJ, Schellekens JFP, Teunis PFM. 2005. Age-specific long-term course of IgG antibodies to pertussis toxin after symptomatic infection with Bordetella pertussis. Epidemiol Infect 133:737–748. http://dx.doi.org/10.1017/S0950268805003833.
246. Hallander HO, Andersson M, Gustafsson L, Ljungman M, Netterlid E. 2009. Seroprevalence of pertussis antitoxin (anti-PT) in Sweden before and 10 years after the introduction of a universal childhood pertussis vaccination program. APMIS 117:912–922. http://dx.doi.org/10.1111/j.1600-0463.2009.02554.x.
247. Teunis PF, van der Heijden OG, de Melker HE, Schellekens JF, Versteegh FG, Kretzschmar ME. 2002. Kinetics of the IgG antibody response to pertussis toxin after infection with B. pertussis. Epidemiol Infect 129:479–489.
248. Hallander HO, Ljungman M, Storsaeter J, Gustafsson L. 2009. Kinetics and sensitivity of ELISA IgG pertussis antitoxin after infection and vaccination with Bordetella pertussis in young children. APMIS 117:797–807. http://dx.doi.org/10.1111/j.1600-0463.2009.02530.x.
249. Esposito S, Agliardi T, Giammanco A, Faldella G, Cascio A, Bosis S, Friscia O, Clerici M, Principi N. 2001. Long-term pertussis-specific immunity after primary vaccination with a combined diphtheria, tetanus, tricomponent acellular pertussis, and hepatitis B vaccine in comparison with that after natural infection. Infect Immun 69:4516–4520. http://dx.doi.org/10.1128/IAI.69.7.4516-4520.2001.
250. Giuliano M, Mastrantonio P, Giammanco A, Bottone M, Piscitelli A, Di Tommaso S, Robino L, Basso F, D’Orazio P. 1997. Antibody kinetics and long-term sero-prevalence in the Italian clinical trial of acellular pertussis vaccines. Dev Biol Stand 89:275–278.
251. Guiso N, Njamkepo E, Vié le Sage F, Zepp F, Meyer CU, Abitbol V, Clyti N, Chevallier S. 2007. Long-term humoral and cell-mediated immunity after acellular pertussis vaccination compares favourably with whole-cell vaccines 6 years after booster vaccination in the second year of life. Vaccine 25:1390–1397. http://dx.doi.org/10.1016/j.vaccine.2006.10.048.
252. Mallet E, Matisse N, Mathieu N, Langue J, Boisnard F, Soubeyrand B, Pentavac Study Group. 2004. Antibody persistence against diphtheria, tetanus, pertussis, poliomyelitis and Haemophilus influenzae type b (Hib) in 5–6-year-old children after primary vaccination and first booster with a pentavalent combined acellular pertussis vaccine: immunogenicity and tolerance of a tetravalent combined acellular pertussis vaccine given as a second booster. Vaccine 22:1415–1422. http://dx.doi.org/10.1016/j.vaccine.2003.10.025.
253. Fry NK, Litt DJ, Duncan J, Vaghji L, Warrener L, Samuel D, Andrews N, Harnden A, Harrison TG. 2013. Modelling anti-pertussis toxin IgG antibody decay following primary and preschool vaccination with an acellular pertussis vaccine in UK subjects using a modified oral fluid assay. J Med Microbiol 62:1281–1289. http://dx.doi.org/10.1099/jmm.0.062000-0.
254. Edelman K, He Q, Mäkinen J, Sahlberg A, Haanperä M, Schuerman L, Wolter J, Mertsola J. 2007. Immunity to pertussis 5 years after booster immunization during adolescence. Clin Infect Dis 44:1271–1277. http://dx.doi.org/10.1086/514338.
255. Pawloski LC, Kirkland KB, Baughman AL, Martin MD, Talbot EA, Messonnier NE, Tondella ML. 2012. Does tetanus-diphtheriaacellular pertussis vaccination interfere with serodiagnosis of pertussis infection? Clin Vaccine Immunol 19:875–880. http://dx.doi.org/10.1128/CVI.05686-11.
256. Keitel WA, Muenz LR, Decker MD, Englund JA, Mink CM, Blumberg DA, Edwards KM. 1999. A randomized clinical trial of acellular pertussis vaccines in healthy adults: dose-response comparisons of 5 vaccines and implications for booster immunization. J Infect Dis 180:397–403. http://dx.doi.org/10.1086/314869.
257. Riffelmann M, Littmann M, Hülsse C, von König CH. 2009. Antibody decay after immunisation of health-care workers with an acellular pertussis vaccine. Eur J Clin Microbiol Infect Dis 28:275–279. http://dx.doi.org/10.1007/s10096-008-0625-0.
258. Litt DJ, Samuel D, Duncan J, Harnden A, George RC, Harrison TG. 2006. Detection of anti-pertussis toxin IgG in oral fluids for use in diagnosis and surveillance of Bordetella pertussis infection in children and young adults. J Med Microbiol 55:1223–1228. http://dx.doi.org/10.1099/jmm.0.46543-0.
259. Campbell H, Amirthalingam G, Fry NK, Litt D, Harrison TG, Wagner K, Crowcroft NS, Miller E. 2014. Oral fluid testing for pertussis, England and Wales, June 2007–August 2009. Emerg Infect Dis 20:968–975. http://dx.doi.org/10.3201/eid2006.131069.
260. Kösters K, Riffelmann M, Dohrn B, von König CH. 2000. Comparison of five commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis. Clin Diagn Lab Immunol 7:422–426.
261. Schellekens JFP, Boshuizen HC, Verbakel JMM, Elvers LH, Boshuis GL, van Houte AJ, Meijer BC, Peeters MF. 2001. Serodiagnosis of pertussis with commercial ELISAs, abstr D-1403, p 163. Int Conf Antimicrob Agents Chemother, Chicago, IL, 22 to 25 September 2001.
262. DeVincenzo JP, Guyton C, Rea H, Elmore E, Patel S, Wynn L, Harrison L, El Saleeby CM, Bagga B. 2013. Molecular detection and quantification of pertussis and correlation with clinical outcomes in children. Diagn Microbiol Infect Dis 76:10–15. http://dx.doi.org/10.1016/j.diagmicrobio.2012.12.015.
263. Erlandsson A, Bäckman A, Nygren M, Lundeberg J, Olcén P. 1998. Quantification of Bordetella pertussis in clinical samples by colorimetric detection of competitive PCR products. APMIS 106:1041–1048. http://dx.doi.org/10.1111/j.1699-0463.1998.tb00256.x.
264. Nakamura Y, Kamachi K, Toyoizumi-Ajisaka H, Otsuka N, Saito R, Tsuruoka J, Katsuta T, Nakajima N, Okada K, Kato T, Arakawa Y. 2011. Marked difference between adults and children in Bordetella pertussis DNA load in nasopharyngeal swabs. Clin Microbiol Infect 17:365–370. http://dx.doi.org/10.1111/j.1469-0691.2010.03255.x.
265. Gao F, Mahoney JC, Daly ER, Lamothe W, Tullo D, Bean C. 2014. Evaluation of a multitarget real-time PCR assay for detection of Bordetella species during a pertussis outbreak in New Hampshire in 2011. J Clin Microbiol 52:302–306. http://dx.doi.org/10.1128/JCM.01656-13.
266. Abu Raya B, Bamberger E, Gershtein R, Peterman M, Srugo I. 2012. The laboratory diagnosis of Bordetella pertussis infection: a comparison of semi-nested PCR and real-time PCR with culture. Eur J Clin Microbiol Infect Dis 31:619–622. http://dx.doi.org/10.1007/s10096-011-1327-6.
267. Holberg-Petersen M, Jenum PA, Mannsåker T, Melby KK. 2011. Comparison of PCR with culture applied on nasopharyngeal and throat swab specimens for the detection of Bordetella pertussis. Scand J Infect Dis 43:221–224. http://dx.doi.org/10.3109/00365548.2010.538855.
268. Leite D, Morozetti Blanco R, Vieira de Melo LC, Fiorio CE, Martins LM, Ibelli Vaz TM, Fernandes SA, Tavares Sacchi C. 2013. Implementation and assessment of the use of real-time PCR in routine diagnosis for Bordetella pertussis detection in Brazil. Arch Pediatr Infect Dis 1:196–202.
269. Palmer CM, McCall B, Jarvinen K, Nissen MD. 2007. Bordetella pertussis PCR positivity, following onset of illness in children under 5 years of age. Commun Dis Intell Q Rep 31:202–205.
270. Cengiz AB, Yildirim I, Ceyhan M, Seçmeer G, Gür D, Kara A. 2009. Comparison of nasopharyngeal culture, polymerase chain reaction (PCR) and serological test for diagnosis of pertussis. Turk J Pediatr 51:309–316.
271. Chia JH, Su LH, Lin PY, Chiu CH, Kuo AJ, Sun CF, Wu TL. 2004. Comparison of multiplex polymerase chain reaction, culture, and serol-ogy for the diagnosis of Bordetella pertussis infection. Chang Gung Med J 27:408–415.
272. Haaheim H, Vorland L, Gutteberg TJ. 2001. Laboratory diagnosis of respiratory diseases: PCR versus serology. Nucleosides Nucleotides Nucleic Acids 20:1255–1258. http://dx.doi.org/10.1081/NCN-100002530.
273. Yildirim I, Ceyhan M, Kalayci O, Cengiz AB, Secmeer G, Gur D, Pelton S. 2008. Frequency of pertussis in children with prolongued cough. Scand J Infect Dis 40:314–319. http://dx.doi.org/10.1080/00365540701689659.
274. Guiso N, Berbers G, Fry NK, He Q, Riffelmann M, Wirsing von König CH, EU Pertstrain Group. 2011. What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories. Eur J Clin Microbiol Infect Dis 30:307–312. http://dx.doi.org/10.1007/s10096-010-1104-y.